Lahore: Ferozsons Laboratories Limited has announced significant leadership appointments following the election of its Board of Directors at an Extraordinary General Meeting. The company disclosed the appointments on July 15, 2026, marking a notable shift in its governance structure.

The newly elected Board has appointed Mrs. Amna Piracha Khan as the Chairperson of the Board. Her appointment signifies a new chapter in the company's strategic direction and governance. Additionally, Mr. Osman Khalid Waheed has been reappointed as the Chief Executive Officer, continuing his role in steering the company's operational and strategic initiatives.

The company operates within the pharmaceutical sector, a designated market category noted for its critical role in healthcare and medicine production. According to information available from the Pakistan Stock Exchange (PSX), these appointments are expected to influence the company's market position and investor confidence positively.

These leadership changes come at a time when Ferozsons Laboratories Limited is poised to enhance its market footprint and operational efficiency. The appointments are anticipated to bolster the company's leadership framework, aligning with its long-term strategic goals.